PT797430E - Formulacao formadora de espuma e espuma - Google Patents

Formulacao formadora de espuma e espuma

Info

Publication number
PT797430E
PT797430E PT95938541T PT95938541T PT797430E PT 797430 E PT797430 E PT 797430E PT 95938541 T PT95938541 T PT 95938541T PT 95938541 T PT95938541 T PT 95938541T PT 797430 E PT797430 E PT 797430E
Authority
PT
Portugal
Prior art keywords
foam
formulation
carrier
foamable
formulation forming
Prior art date
Application number
PT95938541T
Other languages
English (en)
Inventor
Thomas Gilchrist
Eilidh Gilchrist
Original Assignee
Giltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giltech Ltd filed Critical Giltech Ltd
Publication of PT797430E publication Critical patent/PT797430E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Materials For Medical Uses (AREA)
PT95938541T 1994-12-06 1995-12-05 Formulacao formadora de espuma e espuma PT797430E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9424562A GB9424562D0 (en) 1994-12-06 1994-12-06 Product

Publications (1)

Publication Number Publication Date
PT797430E true PT797430E (pt) 2003-10-31

Family

ID=10765469

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95938541T PT797430E (pt) 1994-12-06 1995-12-05 Formulacao formadora de espuma e espuma

Country Status (12)

Country Link
US (1) US6187290B1 (pt)
EP (1) EP0797430B1 (pt)
JP (1) JPH10509724A (pt)
AT (1) ATE241339T1 (pt)
AU (1) AU3990095A (pt)
CA (1) CA2203367C (pt)
DE (1) DE69530939T2 (pt)
DK (1) DK0797430T3 (pt)
ES (1) ES2200008T3 (pt)
GB (1) GB9424562D0 (pt)
PT (1) PT797430E (pt)
WO (1) WO1996017595A1 (pt)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605247D0 (en) * 1996-03-13 1996-05-15 Giltech Ltd Composition
US6656974B1 (en) * 1997-10-17 2003-12-02 Advanced Medical Solutions Limited Foam materials
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
JP4637358B2 (ja) * 1998-10-07 2011-02-23 ギルテック・リミテッド 発泡可能な製剤およびフォーム
WO2001049258A2 (en) * 1999-12-30 2001-07-12 Acrymed Methods and compositions for improved delivery devices
AU2001241644A1 (en) * 2000-02-25 2001-09-03 David Sierra Foam-forming wound dressing
US7137968B1 (en) * 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
DE60107253T2 (de) * 2000-07-27 2005-12-01 Nucryst Pharmaceuticals Corp., Fort Saskatchewan Verwendung von edelmetallen zur herstellung eines arzneitmittels zur behandlung von hyperproliferativen hautstörungen und krankheiten
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US7008647B2 (en) * 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US7255881B2 (en) * 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
ES2261659T3 (es) * 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp. Un medicamento o una preparacion que contiene un metal tal como plata, oro, platino o paladio como un agente antimicrobiano y su uso para el tratamiento de estados inflamatorios de la piel.
JP3950400B2 (ja) * 2001-10-24 2007-08-01 河野製紙株式会社 繊維ウェブ製品、及びその製造方法
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
JP2006509738A (ja) * 2002-10-22 2006-03-23 ニュクリスト ファーマシューティカルズ コーポレーション 予防的治療法
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
KR101108439B1 (ko) * 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
EP1619947A4 (en) * 2003-05-01 2006-05-31 Replidyne Inc ANTIBACTERIAL COMPOSITIONS AND ASSOCIATED METHODS
DE10328261B4 (de) * 2003-06-23 2007-10-25 Beiersdorf Ag Desinfizierende Auflage mit Silberbeschichtung und ihre Verwendung
NZ543643A (en) * 2003-06-23 2007-09-28 Beiersdorf Ag Antimicrobial wound dressing with two layers and antimicrobial metal between layers but not on exterior
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
MXPA06001381A (es) * 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
WO2005048946A2 (en) * 2003-11-15 2005-06-02 Creighton University Treatment for burn victims and animal carcasses
EP1727522A2 (en) * 2004-02-04 2006-12-06 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
EP1746883A4 (en) * 2004-05-13 2009-07-08 Anthony R Talamonti MEDICAL TREATMENT KIT AND METHOD FOR ITS USE
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
CN102783499A (zh) * 2004-07-30 2012-11-21 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
AU2005280443B2 (en) * 2004-07-30 2011-02-03 Avent, Inc. Antimicrobial silver compositions
US9289378B2 (en) * 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
CN101027042B (zh) * 2004-09-23 2012-07-25 陶氏环球技术公司 粘膜或皮肤的药物或卫生***
DE102005017845A1 (de) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
AU2006298442A1 (en) * 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
DE102006001954B4 (de) * 2006-01-16 2013-01-03 Lohmann & Rauscher Gmbh & Co. Kg Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung
BRPI0707382A2 (pt) 2006-01-31 2011-05-03 Tyco Healthcare espumas supermacias
CN101421001B (zh) * 2006-04-11 2013-07-10 泰科保健集团有限合伙公司 多层创伤敷料
EP2015722B1 (en) * 2006-04-28 2016-11-16 Avent, Inc. Antimicrobial site dressings
WO2008005705A2 (en) * 2006-06-30 2008-01-10 Nucryst Pharmaceuticals Corp. Metal-containing formulations and methods of use
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090107007A1 (en) * 2007-10-31 2009-04-30 Mitchellace, Inc. Insole with included aloe extract
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009085651A1 (en) * 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
GB2456212B (en) * 2008-01-09 2012-04-25 Lrc Products Lubricant mousse
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2323480A4 (en) * 2008-08-28 2013-02-27 Covidien Lp ANTIMICROBIAL FOAM COMPOSITIONS, ARTICLES AND ASSOCIATED METHODS
US20100055437A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
CA2743774C (en) * 2008-11-24 2017-11-28 Kimberly-Clark Worldwide, Inc. Antimicrobial laminate constructs
WO2010117266A1 (en) 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9878143B2 (en) 2010-09-30 2018-01-30 Covidien Lp Antimicrobial luer adapter
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
DE102012016275A1 (de) * 2011-08-25 2013-02-28 BonaDea Biotechnologie UG (haftungsbeschränkt) Verfahren zum Schützen von Oberflächen
WO2013110008A1 (en) 2012-01-18 2013-07-25 Worldwide Innovative Healthcare, Inc. Modifiable occlusive skin dressing
EP2944565B1 (en) 2014-05-13 2017-09-27 Entrotech, Inc. Erosion protective sleeve
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2019118458A1 (en) * 2017-12-11 2019-06-20 Respirogen, Inc. Devices and methods for delivery of oxygen to a wound
WO2021014356A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Foam compositions for wound treatment, systems of delivery, and methods of use
CN110628754A (zh) * 2019-10-10 2019-12-31 浙江海洋大学 微生物泡沫型载体及其制备方法、水面石油污染的原位处理方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086331A (en) 1975-01-07 1978-04-25 Technion Research And Development Foundation Ltd. Gelatin-based compositions and a method for the generation of stabilized foams therefrom
DE2544777A1 (de) 1975-10-07 1977-04-21 Bayer Ag Dufttraeger auf basis von carboxymethylcellulose-gelen
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5057606A (en) 1989-01-24 1991-10-15 Minnesota Mining And Manufacturing Company Form-in-place polysaccharide gels
US4948575A (en) * 1989-01-24 1990-08-14 Minnesota Mining And Manufacturing Company Alginate hydrogel foam wound dressing
US5089606A (en) * 1989-01-24 1992-02-18 Minnesota Mining And Manufacturing Company Water-insoluble polysaccharide hydrogel foam for medical applications
JP2847529B2 (ja) * 1989-07-03 1999-01-20 品川燃料株式会社 銀含有化合物の抗菌性向上方法
JPH04282311A (ja) 1991-03-08 1992-10-07 Koike Kagaku Kk エアゾール型発泡性傷口消毒剤
US5851461A (en) * 1992-06-19 1998-12-22 Albany International Research Co. Method of producing polysaccharide foams
EP0612331A4 (en) 1992-06-19 1994-11-23 Albany Int Corp METHOD FOR PRODUCING POLYSACCHARIDE FOAMS.
GB9218749D0 (en) 1992-09-04 1992-10-21 Courtaulds Plc Alginate gels
JPH06279268A (ja) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd 消毒殺菌剤およびこれを含有するエアゾール組成物
US5718916A (en) * 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products

Also Published As

Publication number Publication date
ATE241339T1 (de) 2003-06-15
WO1996017595A1 (en) 1996-06-13
AU3990095A (en) 1996-06-26
EP0797430B1 (en) 2003-05-28
CA2203367C (en) 2007-02-06
DE69530939D1 (de) 2003-07-03
DE69530939T2 (de) 2004-05-19
CA2203367A1 (en) 1996-06-13
ES2200008T3 (es) 2004-03-01
EP0797430A1 (en) 1997-10-01
DK0797430T3 (da) 2003-09-29
US6187290B1 (en) 2001-02-13
JPH10509724A (ja) 1998-09-22
GB9424562D0 (en) 1995-01-25

Similar Documents

Publication Publication Date Title
PT797430E (pt) Formulacao formadora de espuma e espuma
BR8601296A (pt) Composicao de espuma utilizada no tratamento de papel
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
NO933400D0 (no) Fremgangsmaate for fremstilling av for pellets
IE840378L (en) Detergent compositions
HUT60138A (en) Process for producing combination compositions suitable for preventing and/or treating benign prostatic hyperplasia
PL295641A1 (en) Method of obtaining novel polymeric alkyl ammonia derivatives
IL124927A (en) Preservation solution for organs and tissues comprising nitroglycerine and calcium
SE8502553L (sv) Stabila kompositioner
ATE4904T1 (de) Verfahren zur herstellung von 5'-deoxy-5fluoruridin und zwischenprodukte in diesem verfahren.
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
NL7602839A (nl) Werkwijze ter bereiding van een werkzaam bestanddeel voor het veranderen, modificeren of versterken van de organoleptische eigenschappen van bepaalde mate- rialen, alsmede voor het uitvoeren van de laatstge- noemde werkwijze en voor de bereiding van composi- ties, die deze werkzame bestanddelen bevatten.
EP0547102A4 (pt)
TW229232B (pt)
FR2446279B1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
SE8902124L (sv) Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
HUT61561A (en) Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
BG101526A (en) Antiphlogistic composition for external application
NL189803C (nl) Inrichting voor het inweken van mestresten binnen ruimten, zoals stallen en voor het ontsmetten van ruimten.
NL7702801A (nl) Werkwijze voor de bereiding van geneesmiddelen, dergelijke geneesmiddelen en werkwijze voor de bereiding van de werkzame verbindingen.
GR1001412B (el) Συν?έσεις χρήσιμες δια την ?εραπευτική αγωγή της ξηρότητος του κόλπου.
HUT57582A (en) Process for producing n-acylated amino-containing compositions suitable for treating burns
NL7701252A (nl) Werkwijze voor het versterken, verbeteren of modificeren van de geureigenschappen van par- fums en geparfumeerde artikelen.